WHO accepted the recommendation from the Solidarity Trial’s

International Steering Committee to discontinue the trial’s hydroxychloroquine and


By: | on | 289 views
Topic: Opinion


WHO accepted the recommendation from the Solidarity Trial’s

Chevron Nigeria

International Steering Committee to discontinue the trial’s hydroxychloroquine and the lopinavir/ritonavir arms. 

 

Interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized #COVID19 patients when compared to the existing standard of care.

 

The Solidarity Trial was established by WHO to find an effective #COVID19 treatment for hospitalized patients.


Chevron Nigeria Copyright: Fresh Angle International (www.freshangleng.com)


comments powered by Disqus

Sponsored Ads

Business

Are you tired of working long hours, earning peanuts? Want to start a business, but face challenges? Contact Mrs. Victory Ejoh on: 07030270210; 08074435182